This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Laurie H. Glimcher, MD, Dean Of Weill Cornell Medical College, Joins New York Blood Center Board Of Trustees

NEW YORK, June 13, 2013 /PRNewswire-USNewswire/ -- New York Blood Center (NYBC) announced today that Laurie H. Glimcher, MD, Dean of Weill Cornell Medical College, has been elected to the Board of Trustees.

(Photo: http://photos.prnewswire.com/prnh/20130613/DC32105 )

Dr. Glimcher is the Stephen and Suzanne Weiss Dean of Weill Cornell Medical College in New York, where she is also Professor of Medicine. In addition, she is Provost for Medical Affairs of Cornell University.   Previous to her current positions, she was the Irene Heinz Given Professor of Immunology at the Harvard School of Public Health, where she was director of the Division of Biological Sciences, and Professor of Medicine at Harvard Medical School, where she headed one of the top immunology programs in the world. She also served as Senior Physician and Rheumatologist at the Brigham and Women's Hospital.

Howard P. Milstein, Chairman of the Board of the New York Blood Center said, "Laurie's vast experience, energy, unique skill sets, and commitment to the community will make an invaluable contribution to the Board, the entire NYBC organization, and the millions of people we serve."

Dr. Glimcher is a Fellow of the American Academy of Arts and Sciences, and a Member of the National Academy of Sciences (and a Member of its Institute of Medicine). She is the former President of the American Association of Immunologists. She is a member of the American Asthma Foundation, Health Care Ventures, Burroughs-Wellcome Fund and Cancer Research Institute scientific advisory boards. She serves on the Board of Trustees of Memorial Sloan Kettering Cancer Center and is on the Corporate Board of Directors of the Bristol-Myers Squibb Pharmaceutical Corporation and the Waters Corporation.

New York Blood Center (NYBC), provides lifesaving blood transfusion products and medical services to Greater New York's 22 million residents, in addition to operating the world's largest public cord blood bank and a significant medical research institute.  

"We are thrilled to welcome such a renowned physician/scientist and leader to our Board of Trustees," said NYBC President and CEO Christopher D. Hillyer, MD.  "Dr. Glimcher is outstanding in every way.  She understands and participates in the complex and rapidly evolving healthcare, medical and scientific environments within NYBC's landscape."

Dr. Glimcher is the recipient of many awards recognizing her professional contributions, including:  the Soma Weiss Award for Undergraduate Research, the Distinguished Young Investigator Award from the American College of Rheumatology, the Leukemia Society's Stohlman Memorial Scholar Award, the Arthritis Foundation's Lee S. Howley Award, the FASEB Excellence in Science Award, the American Society of Clinical Investigation Investigator Award, the Klemperer Award, the AAUW Senior Scholar Award, the Huang Meritorious Career Award, the AAI Excellence in Mentoring Award, the Dean's Award for Leadership in the Advancement of Women Faculty, the American College of Rheumatology Distinguished Investigator Award, and in 2012 she received the Ernst W. Bertner Memorial Award, MD Anderson Cancer Center, the William B. Coley Award, Cancer Research Institute, and the Luis Federico Leloir Prize for International Cooperation in Science, Technology and Innovation, Ministry of Health, Argentina. Most recently she was the recipient of the Advancing Women in Science and Medicine award.

She received her bachelor's degree from Radcliffe College and her MD from Harvard.

Dr. Glimcher joins Mr. Milstein and the following Trustees on NYBC's Board: Jennifer Jones Austin, Dr. Andrew Bodnar, William W. Crouse, Harriet Edelman, Dr. Owen Garrick, Dr. Christopher Hillyer, Dr. Michael W. Hodin, Marc Kramer, Aaron R. Marcu, Michelle Miao, John R. Mullen, Robert A. Schwartz, Nicholas Scoppetta, Howard Sloan, David Tendler, and John Zuccotti.

About New York Blood Center : New York Blood Center (NYBC) is one of the nation's largest non-profit, community-based blood centers. For almost 50 years, NYBC has been providing blood, transfusion products and services to hospitals serving more than 22 million people in New York City, Long Island, the Hudson Valley, New Jersey, and parts of Connecticut and Pennsylvania. NYBC is also home to the Lindsley F. Kimball Research Institute and the National Cord Blood Program at the Howard P. Milstein National Cord Blood Center, the world's largest public cord blood bank. NYBC provides medical services and programs (Clinical, Transfusion, and Hemophilia Services) through our medical professionals along with consultative services in transfusion medicine. Please visit us on Facebook at www.Facebook.com/newyorkbloodcenter . Follow us on Twitter: @NY_BloodCenter. Website: www.nybloodcenter.org .

Rubenstein Associates Contact: Hope Kaplan (212) 843-8070

SOURCE New York Blood Center

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,960.57 -123.23 -0.72%
S&P 500 1,978.34 -9.64 -0.48%
NASDAQ 4,449.5640 -22.5440 -0.50%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs